DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Accord healthcare
03 2Accure Labs
04 1Apotex Inc
05 1Assia Chemical Industries Ltd
06 1Aurobindo Pharma Limited
07 2Bluepharma
08 1Central Procurement & Supplies Unit
09 1Eugia Pharma
10 2GSK
11 2Glenmark Pharmaceuticals
12 2Intas Pharmaceuticals
13 2Laboratorio Eczane Pharma
14 1Lotus Support Services S.R.L.
15 2Newbury Pharmaceuticals Ab
16 21Novartis Pharmaceuticals Corporation
17 2Novartis South Africa (Pty) Ltd
18 1Novugen
19 2PharOS Ltd
20 2Pharmacare Premium
21 1Pharmascience Inc.
22 2Pinnacle Life Science
23 2Pluviaendo
24 4STADA Arzneimittel
25 2Sakar Healthcare
26 4Sandoz B2B
27 2Spirig Healthcare
28 1Sun Pharmaceutical Industries Limited
29 1Teva Pharmaceutical Industries
30 2TherDose Pharma
31 3Torrent Pharmaceuticals Limited
32 2Zentiva
01 5FCT
02 40Film Coated Tablet
03 2Oral Solid Dosage Form
04 5TABLET
05 8TABLET;ORAL
06 6Tablet
07 4Tablets
08 12Blank
01 6Allowed
02 12Approved
03 7Authorised
04 8Authorized
05 1DISCN
06 5Generic
07 2Lead Market Dossiers- Under Development
08 2Originator
09 3Prescription
10 7RX
11 1Withdrawn
12 28Blank
01 1EUGIA-PAZOPANIB
02 6PAZOPANIB HYDROCHLORIDE
03 1PAZOTEV 400
04 1PMS-PAZOPANIB
05 1Pazitorz 200 mg
06 1Pazitorz 400 mg
07 2Pazopane
08 4Pazopanib Accord
09 4Pazopanib Glenmark
10 2Pazopanib Hydrochloride
11 1Pazopanib Lotus
12 2Pazopanib Newbury
13 2Pazopanib Pharmacare
14 2Pazopanib Pharos
15 3Pazopanib Sandoz
16 1Pazopanib Sandoz film-coated tablets
17 2Pazopanib Spirig HC
18 4Pazopanib Stada
19 2Pazopanib Zentiva
20 1Pyzypi
21 3VOTRIENT
22 18Votrient
23 1Votrient 200 mg
24 1Votrient 400 mg
25 16Blank
01 2Argentina
02 12Australia
03 3Canada
04 14India
05 8Malta
06 2Portugal
07 5South Africa
08 8Spain
09 12Sweden
10 6Switzerland
11 2Turkey
12 8USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Pazitorz 200 mg
Dosage Form : FCT
Dosage Strength : 200mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Pazitorz 400 mg
Dosage Form : FCT
Dosage Strength : 400mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217517
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-12-04
Application Number : 219034
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info : RX
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-04-23
Application Number : 218231
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 215837
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE
Packaging :
Approval Date : 2025-09-04
Application Number : 219922
Regulatory Info : RX
Registration Country : USA
